Skip to main content
Clinical Trials/NCT01663493
NCT01663493CompletedNot Applicable

Randomized Trial Comparing 2 Needles During EUS-FNA of Solid Pancreatic Masses

Brigham and Women's Hospital1 site in 1 country59 target enrollmentStarted: October 1, 2015Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
59
Locations
1
Primary Endpoint
number of passes

Study Overview

Brief Summary

This study will examine whether there is any difference in number of passes needed to diagnose pancreatic masses during endoscopic ultrasound-guided biopsies using 2 different types of needles.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to 100 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •pancreas mass

Exclusion Criteria

  • •coagulopathy
  • •mass not approachable by endoscopic ultrasound biopsy

Arms & Interventions

Fine needle aspiration needle

Other

standard Beacon FNA needle

Intervention: FNB (Procedure)

fine needle biopsy needle

Other

SharkCore fine needle biopsy needle

Intervention: FNB (Procedure)

Outcomes

Primary Outcomes

number of passes

Time Frame: 1 week

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Linda S. Lee

Assistant Professor of Medicine

Brigham and Women's Hospital

Study Sites (1)

Loading locations...

Similar Trials